Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
"Lysosomal glycogen storage disease with normal acid maltase" which was originally described by Danon et al., is characterized clinically by cardiomyopathy, myopathy and variable mental retardation. The pathological hallmark of the disease is intracytoplasmic vacuoles containing autophagic material and glycogen in skeletal and cardiac muscle cells. Sarcolemmal proteins and basal lamina are associated with the vacuolar membranes. Here we report ten unrelated patients, including one of the patients from the original case report, who have primary deficiencies of LAMP-2, a principal lysosomal membrane protein. From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon disease. To our knowledge this is the first example of human cardiopathy-myopathy that is caused by mutations in a lysosomal structural protein rather than an enzymatic protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| Cardiomyopathies | Whole‐body deletion of Lamp2 | Accelerated development of a vacuolar cardioskeletal myopathy similar to Danon disease | Nishino et al (2000), Tanaka et al (2000) |”
From Autophagy in major human diseases (2021) · cites this paper as Nishino et al (2000)
In the citing paper
“In addition, broad‐spectrum autophagic defects tied to the systemic ablation of LAMP2 (causing Danon disease) account for the early development of hypertrophic cardiomyopathy (Nishino et al, 2000; Tanaka et al, 2000).”
From Autophagy in major human diseases (2021) · cites this paper as Nishino et al, 2000
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
An association between migraine and cutaneous allodynia
Burstein, R., Yarnitsky, D., Goor‐Aryeh, I., Ransil, B. J., & Bajwa, Z. H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5<684::aid-ana27>3.0.co;2-o · Cited by 1,025
Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice
Tanaka, Y., Guhde, G., Suter, A., Eskelinen, E.-L., Hartmann, D., Lüllmann-Rauch, R., Janssen, P. M. L., Blanz, J., von Figura, K., & Saftig, P. (2000) · Nature · doi:10.1038/35022595 · Cited by 925 · cited 1×
“From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon diseas”
ResultA novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis
Town, M., Jean, G., Cherqui, S., Attard, M., Forestier, L., Whitmore, S. A., Callen, D. F., Gribouval, O., Broyer, M., Bates, G. P., et al. (1998) · Nature Genetics · doi:10.1038/ng0498-319 · Cited by 639 · cited 1×
“Our results, together with the recent identification of mutations in the lysosomal proteins cystinosin and sialin that cause nephropathic cystinosi”
ResultLysosomal glycogen storage disease with normal acid maltase
Danon, M. J., Oh, S. J., DiMauro, S., Manaligod, J. R., Eastwood, A., Naidu, S., & Schliselfeld, L. H. (1981) · Neurology · doi:10.1212/wnl.31.1.51 · Cited by 405 · cited 4×
“In 1981, Danon et al.1 reported two boys with the clinical triad of cardiomyopathy, myopathy and mental retardation.”
BackgroundInfluentialSelf-citationSaitoh, O., Wang, W. C., Lotan, R., & Fukuda, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42823-2 · Cited by 308
A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases
Verheijen, F. W., Verbeek, E., Aula, N., Beerens, C. E. M. T., Havelaar, A. C., Joosse, M., Peltonen, L., Aula, P., Galjaard, H., van der Spek, P. J., et al. (1999) · Nature Genetics · doi:10.1038/70585 · Cited by 293
Lysosomes, a meeting point of proteins, chaperones, and proteases
Cuervo, A. M., & Dice, J. F. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050185 · Cited by 201 · cited 1×
“Alternatively, the unusual muscle pathology in DD might result from impaired lysosomal protein processing because the cytoplasmic tail of LAMP-2 functions as a receptor for the uptake of certain proteins into lysosome in association with the relative molecular mass ( M r ) 73,000 heat shock cognate protei”
BackgroundPattern of malformations in the axial skeleton in human triploid fetuses
Kjær, I., Keeling, J. W., Smith, N. M., & Hansen, B. F. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19971017)72:2<135::aid-ajmg3>3.0.co;2-u · Cited by 120
Konecki, D. S., Foetisch, K., Zimmer, K.-P., Schlotter, M., & Konecki, U. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2528 · Cited by 116 · cited 1×
“Human exon 9 exists in two forms, 9a and 9b, which are alternatively spliced and produce two isoforms, LAMP-2a and LAMP-2b, respectivel”
Background
Research works printed but not linked: 1
- Lewin, B. Genes VI (Oxford Univ. Press, Oxford, 1997).
Cited by
Items 301–400 of 1,000
Emerging roles for the ubiquitin-proteasome system and autophagy in pancreatic beta-cells.
Hartley, T., Brumell, J., & Volchuk, A. (2009) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.90538.2008 · Cited by 56
“LAMP-2, which is a known to play a significant role in autophagy (27, 86), may be a potential regulator of granule degradation in -cells.”
Takemura, G., Kanamori, H., Okada, H., Miyazaki, N., Watanabe, T., Tsujimoto, A., Goto, K., Maruyama, R., Fujiwara, T., & Fujiwara, H. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9708-x · Cited by 67
Clinical Profile of Cardiac Involvement in Danon Disease: A Multicenter European Registry
Lotan, D., Salazar‐Mendiguchía, J., Mogensen, J., Rathore, F., Anastasakis, A., Kaski, J. P., García‐Pavía, P., Olivotto, I., Charron, P., Biagini, E., et al. (2020) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.120.003117 · Cited by 68
Schorderet, D. F. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.2.231 · Cited by 66
“Danon disease results from mutations in the lysosome-associated membrane protein-2 (LAMP2) gene.(1) The first report of its occurrence seems to be from Danon et al(2) in 1981, although Antopol et al(3) described in 1940 two brothers who died from heart failure due to a glycogen storage disease restricted to the heart…”
Chaperone-assisted proteostasis is essential for mechanotransduction in mammalian cells
Ulbricht, A., Arndt, V., & Höhfeld, J. (2013) · Communicative & Integrative Biology · doi:10.4161/cib.24925 · Cited by 67
Stypmann, J., Janssen, P. M. L., Prestle, J., Engelen, M. A., Kögler, H., Lüllmann‐Rauch, R., Eckardt, L., FIGURA, K. V., Landgrebe, J., Mleczko, A. M., et al. (2006) · Basic Research in Cardiology · doi:10.1007/s00395-006-0591-6 · Cited by 66
“Thus, LAMP-2 deficient mice represent a valuable animal model for a mutated LAMP-2-gene-associated disease [34].”
BackgroundWohlgemuth, S. E., Lees, H. A., Marzetti, E., Manini, T. M., Aranda, J. M., Daniels, M. J., Pahor, M., Perri, M. G., Leeuwenburgh, C., & Anton, S. D. (2011) · Rejuvenation Research · doi:10.1089/rej.2010.1132 · Cited by 65
“40 43 Our findings suggest that autophagy may play an important part in WL þ E–induced improvement of physical performance through enhanced cellular quality control.”
van Mil, A., Balk, G. M., Neef, K., Buikema, J. W., Asselbergs, F. W., Wu, S. M., Doevendans, P. A., & Sluijter, J. P. G. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy208 · Cited by 65
“Patients present with severe cardiac and skeletal muscle abnormalities resulting in HCM, heart failure and sudden cardiac death.(173) In”
BackgroundImpact of cellular autophagy on viruses: Insights from hepatitis B virus and human retroviruses
Tang, S.-W., Ducroux, A., Jeang, K., & Neuveut, C. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-92 · Cited by 65
“The deficiency of LAMP-2 in mice also results in similar vacuolar cardioskeletal myopathy [53].”
BackgroundVesa, J., Su, H., Watts, G. D., Krause, S., Walter, M. C., Martin, B., Smith, C., Wallace, D. C., & Kimonis, V. E. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.08.003 · Cited by 61
“This disease is caused by mutations in the Lamp2 gene that encodes a lysosomal membrane protein [28].”
BackgroundComprehensive autophagy evaluation in cardiac disease models
Kaludercic, N., Maiuri, M. C., Kaushik, S., Fernández, Á. F., de Bruijn, J., Castoldi, F., Chen, Y., Ito, J., Mukai, R., Murakawa, T., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvz233 · Cited by 64
“Among them, the mutation in the LAMP-2 gene that causes Danon’s cardiomyopathy is perhaps the best characterized one.(91,92) In this regard, the pathological hallmark of the disease is the accumulation of intracytoplasmic vacuoles containing autophagic material and glycogen in skeletal and cardiac muscle cells.”
BackgroundYamaguchi, O., & Otsu, K. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31824cc31c · Cited by 64
“Mice with a deficiency of lysosomeassociated membrane protein-2, a model for Danon disease, show an accumulation of autophagic vacuoles and cardiomyopathy.(16,17) Moreover, an inhibition of autophagy has been reported in the progression of cardiac hypertrophy.”
BackgroundMazzarotto, F., Olivotto, I., Boschi, B., Girolami, F., Poggesi, C., Barton, P. J. R., & Walsh, R. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015473 · Cited by 63
Therapeutic Benefit of Autophagy Modulation in Pompe Disease
Lim, J., Sun, B., Puertollano, R., & Raben, N. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.04.025 · Cited by 63
Pérez, L., McLetchie, S., Gardiner, G. J., Deffit, S. N., Zhou, D., & Blum, J. S. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501476 · Cited by 62
Lamp1 mediates lipid transport, but is dispensable for autophagy in Drosophila
Chaudhry, N. Y., Sica, M., Surabhi, S., Hernández, D. S., Mesquita, A., Selimovic, A., Riaz, A., Lescat, L., Bai, H., MacIntosh, G. C., et al. (2022) · Autophagy · doi:10.1080/15548627.2022.2038999 · Cited by 62
“suggest, that, in contrast to humans and mice [21-24], there is no basal or starvation induced MA defect in the absence of Lamp1 in Drosophila.”
BackgroundChen-Scarabelli, C. A., Agrawal, P. R., Saravolatz, L. D., Abuniat, C., Scarabelli, G., Stephanou, A., Loomba, L., Narula, J., Scarabelli, T. M., & Knight, R. A. (2014) · 老年心脏病学杂志:英文版 · doi:10.11909/j.issn.1671-5411.2014.01.009 · Cited by 62
Cui, D., Sun, D., Wang, X., Yi, L., Kulikowicz, E., Reyes, M., Zhu, J., Yang, Z.-J., Jiang, W., & Koehler, R. C. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.318 · Cited by 62
Cell Type-specific Functions of the Lysosomal Protease Cathepsin L in the Heart
Spira, D., Stypmann, J., Tobin, D. J., Petermann, I., Mayer, C., Hagemann, S., Vasiljeva, O. S., Günther, T., Schüle, R., Peters, C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703447200 · Cited by 62
The Impact of Autophagy on Cardiovascular Senescence and Diseases
Sasaki, Y., Ikeda, Y., Iwabayashi, M., Akasaki, Y., & Ohishi, M. (2017) · International Heart Journal · doi:10.1536/ihj.17-246 · Cited by 56
ATP-Binding Cassette Transporters in the Heart
Solbach, T. F., König, J., Fromm, M. F., & Zolk, O. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.10.001 · Cited by 61
Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
Giacomelli, E., Mummery, C. L., & Bellin, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2546-5 · Cited by 60
Xu, Z., Pan, Z., Jin, Y. H., Gao, Z., Jiang, F., Fu, H., Chen, X., Zhang, X., Yan, H., Yang, X., et al. (2023) · Autophagy · doi:10.1080/15548627.2023.2259216 · Cited by 60
Role of Autophagy in Proteostasis: Friend and Foe in Cardiac Diseases
Li, J., Zhang, D., Wiersma, M., & Brundel, B. J. J. M. (2018) · Cells · doi:10.3390/cells7120279 · Cited by 60
Li, P., Dong, X., Zhang, B., Zhang, X., Liu, J.-Z., Ma, D., & Ma, L. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001772 · Cited by 60
The First Molecular Evidence That Autophagy Relates Rimmed Vacuole Formation in Chloroquine Myopathy
Suzuki, T., Nakagawa, M., Yoshikawa, A., Sasagawa, N., Yoshimori, T., Ohsumi, Y., Nishino, I., Ishiura, S., & Nonaka, I. (2002) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a003147 · Cited by 59
Self-citationLAMP‐2‐deficient human B cells exhibit altered MHC class II presentation of exogenous antigens
Crotzer, V. L., Glosson, N., Zhou, D., Nishino, I., & Blum, J. S. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03309.x · Cited by 59
Self-citationThe Glycogen Storage Diseases and Related Disorders
Smit, G., Rake, J. P., Akman, H. O., & DiMauro, S. (2006) · Springer eBooks · doi:10.1007/978-3-540-28785-8_6 · Cited by 59
Self-citationZech, A. T. L., Singh, S. R., Schlossarek, S., & Carrier, L. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.01.013 · Cited by 59
Mitochondrial Autophagy: – An Essential Quality Control Mechanism for Myocardial Homeostasis –
Thomas, R. L., & Gustafsson, Å. B. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0835 · Cited by 58
Kyöstilä, K., Syrjä, P., Jagannathan, V., Chandrasekar, G., Jokinen, T. S., Seppälä, E. H., Becker, D., Drögemüller, M., Dietschi, E., Drögemüller, C., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005169 · Cited by 58
Beyond starvation: An update on the autophagic machinery and its functions
Kawabata, T., & Yoshimori, T. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.12.005 · Cited by 58
Amelioration of X-Linked Related Autophagy Failure in Danon Disease With DNA Methylation Inhibitor
Ng, K., Mok, P. Y., Butler, A. W., Ho, J. C.-Y., Choi, S. W., Lee, Y.-K., Lai, W., Au, K., Lau, Y., Wong, L., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.019847 · Cited by 58
Autophagy in cardiovascular health and disease
Abdellatif, M., Ljubojević-Holzer, S., Madeo, F., & Sedej, S. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.022 · Cited by 59
The role of autophagic degradation in the heart
Nishida, K., Taneike, M., & Otsu, K. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.09.029 · Cited by 57
McCracken, A. A., & Brodsky, J. L. (2006) · Springer eBooks · doi:10.1007/3-540-28007-3_2 · Cited by 57
Balmer, C., Ballhausen, D., Bosshard, N. U., Steinmann, B. U., Boltshauser, E., Bauersfeld, U., & Superti‐Furga, A. (2005) · European Journal of Pediatrics · doi:10.1007/s00431-005-1678-z · Cited by 56
“The genetic defect has been localised to Xq24, and some 25 mutations have been identified to date [15, 18, 22,26].”
BackgroundGenetics of BAG3: A Paradigm for Developing Precision Therapies for Dilated Cardiomyopathies
Qu, H., Feldman, A. M., & Hakonarson, H. H. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.027373 · Cited by 55
Schroen, B. L. M., Leenders, J. J., van Erk, A., Bertrand, A., van Loon, M., van Leeuwen, R. E. W., Kubben, N., Duisters, R. F. J. J., Schellings, M. W. M., Janssen, B. J., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070145 · Cited by 55
VAMP7 regulates constitutive membrane incorporation of the cold-activated channel TRPM8
Ghosh, D., Pinto, S., Danglot, L., Vandewauw, I., Segal, A., Ranst, N. V., Benoit, M., Janssens, A., Vennekens, R., Berghe, P. V., et al. (2016) · Nature Communications · doi:10.1038/ncomms10489 · Cited by 55
Diagnosis of lysosomal storage disorders: current techniques and future directions
Meikle, P. J., Fietz, M. J., & Hopwood, J. J. (2004) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.4.5.677 · Cited by 54
Mammalian Apg12p, but not the Apg12p · Apg5p conjugate, facilitates LC3 processing
Tanida, I., Nishitani, T., Nemoto, T., Ueno, T., & Kominami, E. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02057-0 · Cited by 55
Characterization of Danon disease in a male patient and his affected mother
Sugie, K., Koori, T., Yamamoto, A., Ogawa, M., Hirano, M., Inoue, K., Nonaka, I., & Nishino, I. (2003) · Neuromuscular Disorders · doi:10.1016/s0960-8966(03)00105-6 · Cited by 54
Self-citationWei, C., Li, H., Han, L., Zhang, L., & Yang, X. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318287d501 · Cited by 53
“Moreover, Danon cardiomyopathy, an X-linked genetic disorder, is due to a deficiency of lysosomal-associated membrane protein 2, which results in a disruption in the autophagosome–lysosome pathway and autophagosome accumulation in the myocardium.(4) Ischemic postconditioning (IPost), defined as transient episodes of i…”
BackgroundPan, M., Zheng, Z., Chen, Y., Sun, N., Zheng, B., Yang, Q., Zhang, Y., Li, X., & Meng, Y. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0284oc · Cited by 53
Modulating Chaperone-Mediated Autophagy and Its Clinical Applications in Cancer
Hubert, V., Weiss, S., Rees, A. J., & Kain, R. (2022) · Cells · doi:10.3390/cells11162562 · Cited by 53
“Moreover, and as exemplified by the severe phenotype observed both in LAMP-2 deficient mice [64] as well as in patients suffering from Danon’s disease associated with a loss of LAMP-2 function, a therapeutic approach modulating LAMP-2 seems not practical [65].”
BackgroundBcl-2–associated athanogene 3 protects the heart from ischemia/reperfusion injury
Su, F., Myers, V. D., Knezevic, T., Wang, J., Gao, E., Madesh, M., Tahrir, F. G., Gupta, M., Gordon, J., Rabinowitz, J. E., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.90931 · Cited by 52
The lysosomal polypeptide transporter TAPL is stabilized by the interaction with LAMP-1 and LAMP-2
Demirel, Ö., Jan, I., Wolters, D. A., Blanz, J., Säftig, P., Tampé, R., & Abele, R. (2012) · Journal of Cell Science · doi:10.1242/jcs.087346 · Cited by 52
“Danon disease, characterized by hypertrophic cardiomyopathy, skeletal myopathy and variable mental retardation, is caused by mutations of the X-linked gene encoding for the lysosomeassociated membrane protein type 2 (LAMP-2) (Nishino et al., 2000).”
BackgroundLaing, N. G. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282ef6e69 · Cited by 52
Important Role of Autophagy in Regulation of Metabolic Processes in Health, Disease and Aging
Papáčková, Z., & Cahová, M. (2014) · Physiological Research · doi:10.33549/physiolres.932684 · Cited by 51
“Glycogen granules accumulate in muscles of Danon disease patients resulting in cardiomyopathy, proximal muscle weakness and mental retardation (Nishino et al. 2000).”
BackgroundA Nationwide Survey on Danon Disease in Japan
Sugie, K., Komaki, H., Eura, N., Shiota, T., Onoue, K., Tsukaguchi, H., Minami, N., Ogawa, M., Kiriyama, T., Kataoka, H., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113507 · Cited by 51
“On the other hand, human exon 9 of LAMP-2 exists in two forms, exon 9a and 9b, which are alternatively spliced and produce two isoforms, LAMP-2a and LAMP-2b [1].”
BackgroundMethodResultInfluentialSelf-citationCaenorhabditis elegans as a model for lysosomal storage disorders
de Voer, G., Peters, D. J. M., & Taschner, P. E. M. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.04.003 · Cited by 51
“elegans LMP-1 protein, homologous to the Danon disease protein LAMP2, involved in lysosome biogenesis Mutations in the lysosome-associated membrane protein-2 gene (LAMP2) cause glycogen storage disease type IIb or Danon disease, characterized by cardiomyopathy, myopathy and variable mental retardation [39].”
BackgroundMorell, C., Bort, A., Vara-Ciruelos, D., Ramos-Torres, Á., Altamirano-Dimas, M., Díaz-Laviada, I., & Rodríguez-Henche, N. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162977 · Cited by 50
“Reduced fusion has been shown in cells depleted of LAMP2 as demonstrated in LAMP2 knockout mice which showed accumulation of autophagic vacuoles in several tissues [25] and in patients with Danon disease [26, 27].”
BackgroundCardiovascular magnetic resonance findings in a case of Danon disease
Piotrowska‐Kownacka, D., Kownacki, Ł., Kuch, M., Walczak, E., Kosieradzka, A., Fidziańska, A., & Królicki, L. (2009) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-11-12 · Cited by 50
Impact of Chaperone-Mediated Autophagy in Brain Aging: Neurodegenerative Diseases and Glioblastoma
Auzmendi-Iriarte, J., & Matheu, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.630743 · Cited by 50
Afzaal, A., Rehman, K., Kamal, S., & Akash, M. S. H. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23047 · Cited by 50
Lacoste-Collin, L., Garcia, V., Uro‐Coste, E., Arné‐Bes, M., Durand, D., Levade, T., & Delisle, M. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00179-7 · Cited by 50
Shayman, J. A., & Larsen, S. D. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r047167 · Cited by 50
“LAMP2 and Danon disease) (22), and the loss of transporter activity (e.”
BackgroundCheng, Z., Cui, Q., Tian, Z., Xie, H., Chen, L., Lu, F. Y., Zhu, K., & Fang, Q. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr420 · Cited by 50
Castets, P., Frank, S., Sinnreich, M., & Rüegg, M. A. (2016) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-160153 · Cited by 49
“Indeed, vacuoles containing glycogen and autophagic debris, surrounding acid phosphatase-positive basophilic granules recognized as lysosomes, accumulate in muscle biopsies from Danon patients [202].”
BackgroundLoss of APOBEC1 RNA-editing function in microglia exacerbates age-related CNS pathophysiology
Cole, D. C., Chung, Y., Gagnidze, K., Hajdarovic, K. H., Rayon-Estrada, V., Harjanto, D., Bigio, B., Gal-Toth, J., Milner, T. A., McEwen, B. S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710493114 · Cited by 49
Mahogunin regulates fusion between amphisomes/MVBs and lysosomes via ubiquitination of TSG101
Majumder, P., & Chakrabarti, O. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.257 · Cited by 49
“membrane protein LAMP2 result in general myopathy and cardiomyopathy.(6,7) Lysosomal degradation is essential for”
BackgroundBasal autophagy protects cardiomyocytes from doxorubicin-induced toxicity
Pizarro, M., Troncoso, R., Martínez, G. J., Chiong, M., Castro, P., & Lavandero, S. (2016) · Toxicology · doi:10.1016/j.tox.2016.09.011 · Cited by 49
Parkin-mediated mitophagy and autophagy flux disruption in cellular models of MERRF syndrome
Paz, M. V., Povea-Cabello, S., Villalón-García, I., Álvarez-Córdoba, M., Suarez-Rivero, J. M., Talaverón-Rey, M., Jackson, S., Falcón‐Moya, R., Moreno, A. R., & Sánchez-Alcázar, J. A. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165726 · Cited by 49
Impairment of autophagy: From hereditary disorder to drug intoxication
Aki, T., Funakoshi, T., Unuma, K., & Uemura, K. (2013) · Toxicology · doi:10.1016/j.tox.2013.07.001 · Cited by 51
Infantile autophagic vacuolar myopathy is distinct from Danon disease
Yamamoto, A., Morisawa, Y., Verloès, A., Murakami, N., Hirano, M., Nonaka, I., & Nishino, I. (2001) · Neurology · doi:10.1212/wnl.57.5.903 · Cited by 49
Self-citationSex‐Related Differences in Genetic Cardiomyopathies
Argirò, A., Ho, C., Day, S. M., van der Velden, J., Cerbai, E., Saberi, S., Tardiff, J. C., Lakdawala, N. K., & Olivotto, I. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024947 · Cited by 48
Nishida, K., & Otsu, K. (2008) · Circulation Journal · doi:10.1253/circj.cj-08-0669 · Cited by 48
Bottillo, I., Giordano, C., Cerbelli, B., D’Angelantonio, D., Lipari, M., Polidori, T., Majore, S., Bertini, E., D’Amico, A., Giannarelli, D., et al. (2016) · Cardiovascular Pathology · doi:10.1016/j.carpath.2016.07.005 · Cited by 48
“However, most of the splice site alterations map in intron 6 [5,8,25,29], and none of themmaps in introns 3 or 4.”
BackgroundFuqua, J. D., Mere, C. P., Kronemberger, A., Blomme, J., Bae, D., Turner, K. D., Harris, M. P., Scudese, E., Edwards, M., Ebert, S. M., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900766r · Cited by 47
Novel CLN3 mutation causing autophagic vacuolar myopathy
Cortese, A., Tucci, A., Piccolo, G., Galimberti, C. A., Fratta, P., Marchioni, E., Grampa, G., Cereda, C., Grieco, G. S., Ricca, I., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000490 · Cited by 47
Echaniz‐Laguna, A., Mohr, M., Epailly, É., Nishino, I., Charron, P., Richard, P., Guiraud-Chaumeil, C., & Tranchant, C. (2005) · Muscle & Nerve · doi:10.1002/mus.20471 · Cited by 47
Self-citationTowbin, J. A. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2009.02381.x · Cited by 47
Unuma, K., Aki, T., Funakoshi, T., Yoshida, K.-I., & Uemura, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056526 · Cited by 46
Rosmini, S., Biagini, E., O’Mahony, C., Bulluck, H., Ruozi, N., Lopes, L. R., Guttmann, O. P., Réant, P., Quarta, C. C., Pantazis, A. A., et al. (2016) · Heart · doi:10.1136/heartjnl-2016-310138 · Cited by 46
Disrupted autophagy undermines skeletal muscle adaptation and integrity
Jokl, E. J., & Blanco, G. (2016) · Mammalian Genome · doi:10.1007/s00335-016-9659-2 · Cited by 46
“Danon disease is characterized by the presence of autophagic vacuoles with sarcolemmal features (Nishino et al. 2000).”
InfluentialLAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart
Alcalai, R., Arad, M., Wakimoto, H., Yadin, D., Gorham, J., Wang, L., Burns, E., Maron, B. J., Roberts, W. C., Konno, T., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018829 · Cited by 46
A novel form of autophagic vacuolar myopathy with late-onset and multiorgan involvement
Kaneda, D., Sugie, K., Yamamoto, A., Matsumoto, H., Kato, T., Nonaka, I., & Nishino, I. (2003) · Neurology · doi:10.1212/01.wnl.0000069605.00498.bd · Cited by 46
Self-citationDvornikov, A. V., Wang, M., Yang, J., Zhu, P., Le, T., Lin, X., Cao, H., & Xu, X. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.06.013 · Cited by 45
“Mutations in LAMP2 linked to Danon disease are mainly located in the region coding N-terminal part of the protein affecting all three isoforms [4, 13, 14].”
BackgroundInherited disorders of lysosomal membrane transporters
Huizing, M., & Gahl, W. A. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183336 · Cited by 39
“We also exclude lysosome-associated membrane proteins that have no demonstrated transport activity themselves, such as OSTM1 and TCIRG1 associated with osteopetrosis [10,11], ABCD4 associated with cobalamin F disease [12], and LAMP-2 associated with Danon disease [13].”
BackgroundLysosomal Membrane Proteomics and Biogenesis of Lysosomes
Bagshaw, R. D., Mahuran, D. J., & Callahan, J. W. (2005) · Molecular Neurobiology · doi:10.1385/mn:32:1:027 · Cited by 45
McCormick, J. J., Dokładny, K., Moseley, P. L., & Kenny, G. P. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00542.2020 · Cited by 44
López‐Sainz, Á., Salazar‐Mendiguchía, J., García‐Álvarez, A., Campuzano, Ó., López-Garrido, M. Á., García-Guereta, L., Cañamero, M. E. F., Climent, V. E., Peña‐Peña, M. L., Zorio, E., et al. (2018) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2018.04.035 · Cited by 44
“0005).(1) Thus, unlike other glycogen storage diseases, DD is caused not by a deficit in acid maltase, but by the alteration in the transport protein LAMP-2.”
BackgroundSelf-Eating for Muscle Fitness: Autophagy in the Control of Energy Metabolism
Sebastián, D., & Zorzano, A. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.06.030 · Cited by 46
The integral membrane of lysosomes: Its proteins and their roles in disease
Callahan, J. W., Bagshaw, R. D., & Mahuran, D. J. (2008) · Journal of Proteomics · doi:10.1016/j.jprot.2008.11.007 · Cited by 44
Titin truncations lead to impaired cardiomyocyte autophagy and mitochondrial function in vivo
Zhou, J., Ng, B., Ko, N. S. J., Fiedler, L. R., Khin, E. S. W., Lim, A. R., Sahib, N. B. E., Wu, Y., Chothani, S. P., Schäfer, S., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz033 · Cited by 43
Metabolic Alterations in Inherited Cardiomyopathies
Sacchetto, C., Sequeira, V., Bertero, E., Dudek, J., Maack, C., & Calore, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122195 · Cited by 44
Rodrigues, P. M., Sousa, L. G., Perrod, C., Maceiras, A. R., Ferreirinha, P., Pombinho, R., Romera‐Cárdenas, G., Gómez-Lázaro, M., Senkara, M., Pistolic, J., et al. (2022) · Autophagy · doi:10.1080/15548627.2022.2074105 · Cited by 43
“In man, genetic mutations in LAMP2 are associated with Danon Disease, a fatal X-linked syndrome caused by lysosomal dysfunction [22].”
BackgroundSialin expression in the CNS implicates extralysosomal function in neurons
Aula, N., Kopra, O., Jalanko, A., & Peltonen, L. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.11.017 · Cited by 43
Autophagy in the intestinal epithelium regulates Citrobacter rodentium infection
Inoue, J., Nishiumi, S., Fujishima, Y., Masuda, A., Shiomi, H., Yamamoto, K., Nishida, M., Azuma, T., & Yoshida, M. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.03.019 · Cited by 43
Cardiac arrhythmias in patients with Danon disease
Konrad, T., Sonnenschein, S., Schmidt, F. P., Mollnau, H., Bock, K., Ocete, B. Q., Münzel, T. F., Theis, C., & Rostock, T. (2016) · EP Europace · doi:10.1093/europace/euw215 · Cited by 43
“0005).(2) Further clinical manifestations contain retinal, pulmonary, and hepatic dysfunction.”
BackgroundAzzella, M. M., Bolpagni, R., & Oggioni, A. (2014) · Journal of Limnology · doi:10.4081/jlimnol.2014.932 · Cited by 43
Overexpression of autophagic proteins in the skeletal muscle of sporadic inclusion body myositis
Girolamo, F., Lia, A., Amati, A., Strippoli, M., Coppola, C., Virgintino, D., Roncali, L., Toscano, A., Serlenga, L., & Trojano, M. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12040 · Cited by 42
How autophagy can restore proteostasis defects in multiple diseases?
Joshi, V., Upadhyay, A., Prajapati, V. K., & Mishra, A. (2020) · Medicinal Research Reviews · doi:10.1002/med.21662 · Cited by 41
Aula, N., Jalanko, A., Aula, P., & Peltonen, L. (2002) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(02)00124-5 · Cited by 41
Protein kinase Cα drives fibroblast activation and kidney fibrosis by stimulating autophagic flux
Xue, X., Ren, J., Sun, X., Gui, Y., Feng, Y., Shu, B., Wei, W., Lu, Q., Liang, Y., He, W., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002191 · Cited by 40
“It was previously shown that mutation of LAMP-2 causes X-linked vacuolar cardiomyopathy and myopathy (also called Danon disease) (42).”
BackgroundBottillo, I., D’Angelantonio, D., Caputo, V., Paiardini, A., Lipari, M., Bernardo, C. D., Giannarelli, D., Pizzuti, A., Majore, S., Castori, M., et al. (2015) · Gene · doi:10.1016/j.gene.2015.11.048 · Cited by 40
“F151fs mutation in LAMP2, the gene causing Danon's disease, an X-linked dominant disorder predominantly affecting cardiac muscle (Nishino et al., 2000).”
BackgroundAbnormal LAMP1 glycosylation may play a role in Niemann-Pick disease, type C pathology
Cawley, N. X., Sojka, C., Cougnoux, A., Lyons, A. T., Nicoli, E., Wassif, C. A., & Porter, F. D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227829 · Cited by 40
“Lamp2mice recapitulate Danon disease, an X-linked lysosomal storage disorder characterized by (cardio)myopathy and intellectual dysfunction [17, 18].”
BackgroundMoments in autophagy and disease: Past and present
Wen, X., Yang, Y., & Klionsky, D. J. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100966 · Cited by 40
Schnebert, S., Goguet, M., Vélez, E. J., Depincé, A., Beaumatin, F., Herpin, A., & Seiliez, I. (2022) · Cells · doi:10.3390/cells11121945 · Cited by 40
“Instead, LAMP2B is involved in macroautophagy [55,56] and the LAMP2C in the uptake and degradation of DNA and RNA molecules by lysosomes [57,58].”
Background
Metadata
- Authors
- Nishino, I., Fu, J., Tanji, K., Yamada, T., Shimojo, S., Koori, T., Mora, M., Riggs, J. E., Oh, S. J., Koga, Y., Sue, C. M., Yamamoto, A., Murakami, N., Shanske, S., Byrne, E., Bonilla, E., Nonaka, I., DiMauro, S., & Hirano, M.
- Affiliations
- Columbia University (US)
- Kyushu University (JP)
- St. Marianna University School of Medicine (JP)
- Yokohama Rosai Hospital (JP)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- West Virginia University (US)
- University of Alabama at Birmingham (US)
- Kurume University (JP)
- National Center of Neurology and Psychiatry (JP)
- St Vincent's Hospital Melbourne (AU)
- Corresponding author
- Nishino, Ichizo
- ORCID
- Venue
- Nature
- Published
- 2000-08
- Volume
- 406
- Issue
- 6798
- Pages
- 906-910
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2109716633
- Cited by
- 959
- References
- 28
- Citations by year
- 2026: 24 · 2025: 31 · 2024: 30 · 2023: 44 · 2022: 35 · 2021: 44 · 2020: 45 · 2019: 46 · 2018: 57 · 2017: 45 · 2016: 62 · 2015: 44 · 2014: 40 · 2013: 51 · 2012: 45
- FWCI
- 14.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- Danon disease, lysosomal membrane proteins, lysosomal storage disease, cardiomyopathy, myopathy, intracytoplasmic vacuoles, glycogen storage disease
- MeSH terms
- DNA Mutational Analysis, Female, Humans, Immunohistochemistry, Genetic Linkage, Male, Membrane Glycoproteins, Molecular Sequence Data, Muscular Diseases, Cardiomyopathies, Vacuoles, X Chromosome, Blotting, Western, Antigens, CD, Lysosomal Storage Diseases, Sequence Analysis, DNA, Muscle, Skeletal, Lysosomal Membrane Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.